Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Alzheimer’s Treatments
Low-Dose Lithium Trial Sets the Stage for Future Alzheimer’s Studies
Could Targeting Gum Disease Bacteria Slow Alzheimer’s?
Could Fixing Brain Energy Help Treat Alzheimer’s? Mouse Studies Show Promise
Can Focused Sound Waves Treat Diseases Like Alzheimer’s?
Could Existing Drugs like Viagra Treat Alzheimer’s Disease?
GLP-1 Semaglutide Fails to Slow Alzheimer’s Despite Biomarker Changes
Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
Digital Twins: The Sci-Fi Innovation Behind New Personalized Disease Treatments
When Insurance Refused to Cover His Alzheimer’s Treatment, He Found Another Way
Alzheimer’s Drug Leqembi Approved in Canada
Cassava Fraud Case Dismissed, Closing a Chapter in Alzheimer’s Drug Saga
Inside the First FDA-Cleared Stem Cell Trial for Alzheimer’s
Could Alzheimer’s Drugs Work Better in Pairs? A New Approach for ‘Mabs’
Stem Cells for Alzheimer’s: Dr. Christopher Duma’s New Direct-to-Brain Approach
Australia Drug Regulators Approve Leqembi for Alzheimer’s
Previous
1
2
3
Next
Page load link
Go to Top